The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Inhibition of Nuclear Translocation of Transcription Factor NF-κB by a Synthetic Peptide Containing a Cell Membrane-permeable Motif and Nuclear Localization Sequence
Open accessAbstract
To control agonist-induced nuclear translocation of transcription factor kappa B (NF-kappa B) in intact cells, cell-permeable synthetic peptides were devised. Their import into intact cells was dependent on a hydrophobic region selected from the signal peptide sequences and was verified by their inaccessibility to extracellular proteases and by confocal laser scanning microscopy. When a cell-permeable peptide carried a functional cargo representing the nuclear localization sequence of NF-kappa B p50, it inhibited in a concentration-dependent manner nuclear translocation of NF-kappa B in cultured endothelial and monocytic cells stimulated with lipopolysaccharide or tumor necrosis factor-alpha. Synthetic peptide analogues with deleted hydrophobic cell membrane-permeable motif or with a mutated nuclear localization sequence were inactive. Cell membrane-permeable peptides were not cytotoxic within the concentration range used in these experiments. These results suggest that cell-permeable synthetic peptides carrying a functional cargo can be applied to control signal transduction-dependent subcellular traffic of transcription factors mediating the cellular responses to different agonists. Moreover, this approach can be used to study other intracellular processes involving proteins with functionally distinct domains.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide
Merrifield, R. B. (1963) · Journal of the American Chemical Society · doi:10.1021/ja00897a025 · Cited by 7,647
IκB: a Specific Inhibitor of the NF-κB Transcription Factor
Baeuerle, P. A., & Baltimore, D. (1988) · Science · doi:10.1126/science.3140380 · Cited by 2,155
NF-κB: A pleiotropic mediator of inducible and tissue-specific gene control
Lenardo, M. J., & Baltimore, D. (1989) · Cell · doi:10.1016/0092-8674(89)90833-7 · Cited by 1,585
Activation in vitro of NF-κB" by phosphorylation of its inhibitor IκB"
Ghosh, S., & Baltimore, D. (1990) · Nature · doi:10.1038/344678a0 · Cited by 1,172
Baeuerle, P. A., & Baltimore, D. (1988) · Cell · doi:10.1016/0092-8674(88)90382-0 · Cited by 1,166
von Heijne, G. (1990) · The Journal of Membrane Biology · doi:10.1007/bf01868635 · Cited by 1,137
The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors.
Beg, A. A., & Baldwin, A. S. (1993) · Genes & Development · doi:10.1101/gad.7.11.2064 · Cited by 794
Bovi, P. D., Curatola, A. M., Kern, F. G., Greco, A., Ittmann, M., & Basilico, C. (1987) · Cell · doi:10.1016/0092-8674(87)90331-x · Cited by 508
Henkel, T., Zabel, U., van Zee, K., Müller, J. M., Fanning, E., & Baeuerle, P. A. (1992) · Cell · doi:10.1016/0092-8674(92)90083-o · Cited by 385
Recovery of Mitogenic Activity of a Growth Factor Mutant with a Nuclear Translocation Sequence
Imamura, T., Engleka, K., Zhan, X., Tokita, Y., Forough, R., Roeder, D., Jackson, A., Maier, J. A. M., Hla, T., & Maciag, T. (1990) · Science · doi:10.1126/science.1699274 · Cited by 372
Cited by
Glutamate receptor ion channels
Mayer, M. L. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.05.004 · Cited by 3,640
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
Traynelis, S. F., Wollmuth, L. P., McBain, C. J., Menniti, F. S., Vance, K. M., Ogden, K. K., Hansen, K. B., Yuan, H., Myers, S. J., & Dingledine, R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002451 · Cited by 3,568
“The symmetry mismatch between the ATDs and LBDs arises becarboxylic acid; NVP-AAM077, (R)-[(S)-1-(4-bromo-phenyl)-ethylamino](2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl-phosphonic acid; NGX424, tezampanel; Org 25935, N-methyl-N-(6-methoxy-1phenyl-1,2,3,4-tetrahydronaphthalen-2-ylmethyl)aminomethylcarboxylic a…”
BackgroundInfluentialHaloTag: A Novel Protein Labeling Technology for Cell Imaging and Protein Analysis
Los, G. V., Encell, L. P., McDougall, M. G., Hartzell, D. D., Karassina, N., Zimprich, C., Wood, M. G., Learish, R., Ohana, R. F., Urh, M., et al. (2008) · ACS Chemical Biology · doi:10.1021/cb800025k · Cited by 2,624
Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.
Verma, I. M., Stevenson, J. K., Schwarz, E. M., Van Antwerp, D., & Miyamoto, S. (1995) · Genes & Development · doi:10.1101/gad.9.22.2723 · Cited by 1,724
Futaki, S., Suzuki, T., Ohashi, W., Yagami, T., Tanaka, S., Ueda, K., & Sugiura, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007540200 · Cited by 1,662
Wender, P. A., Mitchell, D. J., Pattabiraman, K., Pelkey, E. T., Steinman, L., & Rothbard, J. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.24.13003 · Cited by 1,615
Control of apoptosis by Rel/NF-κB transcription factors
Barkett, M., & Gilmore, T. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203238 · Cited by 1,204
Digicaylioglu, M., & Lipton, S. A. (2001) · Nature · doi:10.1038/35088074 · Cited by 923
Cell-penetrating peptides: classes, origin, and current landscape
Milletti, F. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.03.002 · Cited by 813
Lindgren, M., Hällbrink, M., Prochiantz, A., & Langel, Ü. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01447-4 · Cited by 803
The TSC-mTOR Signaling Pathway Regulates the Innate Inflammatory Response
Weichhart, T., Costantino, G., Poglitsch, M., Rosner, M., Zeyda, M., Stuhlmeier, K. M., Kolbe, T., Stulnig, T. M., Hörl, W. H., Hengstschläger, M., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.08.012 · Cited by 801
Cell-penetrating peptides: mechanism and kinetics of cargo delivery
Zorko, M., & Langel, Ü. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.10.010 · Cited by 799
Inhibiting NF-κB activation by small molecules as a therapeutic strategy
Gupta, S. C., Sundaram, C., Reuter, S., & Aggarwal, B. B. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.05.004 · Cited by 762
Combs, C. K., Karlo, J. C., Kao, S.-C., & Landreth, G. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-04-01179.2001 · Cited by 721
Mechanisms of NF-κB p65 and strategies for therapeutic manipulation
Giridharan, S., & Srinivasan, M. (2018) · Journal of Inflammation Research · doi:10.2147/jir.s140188 · Cited by 686
Shingo, T., Sorokan, S. T., Shimazaki, T., & Weiss, S. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09733.2001 · Cited by 653
GUPTA, B., LEVCHENKO, T., & TORCHILIN, V (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.10.007 · Cited by 632
Cell-Permeable Peptide Inhibitors of JNK
Bonny, C., Oberson, A., Negri, S., Sauser, C., & Schorderet, D. F. (2001) · Diabetes · doi:10.2337/diabetes.50.1.77 · Cited by 571
Inhibitors of NF-κB signaling: 785 and counting
Gilmore, T. D., & Herscovitch, M. (2006) · Oncogene · doi:10.1038/sj.onc.1209982 · Cited by 569
Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks
Pommier, Y., Sordet, O., Antony, S., Hayward, R. L., & Kohn, K. W. (2004) · Oncogene · doi:10.1038/sj.onc.1207515 · Cited by 560
Das, J., Chen, C.-H., Yang, L., Cohn, L., Ray, P., & Ray, A. (2001) · Nature Immunology · doi:10.1038/83158 · Cited by 518
“SN50 contains a signal sequence of Kaposi's fibroblast growth factor and the nuclear localization sequence of the p50 subunit of NF-κB, which has been shown to block nuclear translocation of activated NF-κ”
BackgroundAn Inflammatory Cascade Leading to Hyperresistinemia in Humans
Lehrke, M., Reilly, M. P., Millington, S. C., Iqbal, N., Rader, D. J., & Lazar, M. A. (2004) · PLoS Medicine · doi:10.1371/journal.pmed.0010045 · Cited by 518
Transduction peptides: from technology to physiology
Joliot, A., & Prochiantz, A. (2004) · Nature Cell Biology · doi:10.1038/ncb0304-189 · Cited by 495
Koenigsknecht-Talboo, J., & Landreth, G. E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1808-05.2005 · Cited by 477
Delivery of bioactive molecules into the cell: the Trojan horse approach
Dietz, G. P. H., & Bähr, M. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.03.005 · Cited by 469
Mitsiades, C. S., Mitsiades, N., Poulaki, V., Schlossman, R., Akiyama, M., Chauhan, D., Hideshima, T., Treon, S. P., Munshi, N. C., Richardson, P. G., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205664 · Cited by 464
Oehlke, J., Scheller, A., Wiesner, B., Krause, E., Beyermann, M., Klauschenz, E., Melzig, M., & Bienert, M. (1998) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00161-8 · Cited by 448
Nuclear transcription factor-κB as a target for cancer drug development
Garg, A., & Aggarwal, B. (2002) · Leukemia · doi:10.1038/sj.leu.2402482 · Cited by 441
Overview of interleukin-2 function, production and clinical applications
GAFFEN, S., & LIU, K. (2004) · Cytokine · doi:10.1016/j.cyto.2004.06.010 · Cited by 431
Ardeshna, K. M., Pizzey, A. R., Devereux, S., & Khwaja, A. (2000) · Blood · doi:10.1182/blood.v96.3.1039 · Cited by 430
TNF-α stimulates activation of pro-MMP2 in human skin through NF-κB mediated induction of MT1-MMP
Han, Y.-P., Tuan, T.-L., Wu, H., Hughes, M., & Garner, W. L. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.1.131 · Cited by 411
Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery
Desai, P., Patlolla, R. R., & Singh, M. (2010) · Molecular Membrane Biology · doi:10.3109/09687688.2010.522203 · Cited by 411
Membrane-permeable arginine-rich peptides and the translocation mechanisms
FUTAKI, S. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.10.009 · Cited by 406
Mitsiades, C. S., Treon, S. P., Mitsiades, N., Shima, Y., Richardson, P., Schlossman, R., Hideshima, T., & Anderson, K. C. (2001) · Blood · doi:10.1182/blood.v98.3.795 · Cited by 392
The anti-inflammatory effects of heparin and related compounds
Young, E. (2008) · Thrombosis Research · doi:10.1016/j.thromres.2006.10.026 · Cited by 390
Huang, T. T., Kudo, N., Yoshida, M., & Miyamoto, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1014 · Cited by 380
Biologic sequelae of nuclear factor–κB blockade in multiple myeloma: therapeutic applications
Mitsiades, N., Mitsiades, C. S., Poulaki, V., Chauhan, D., Richardson, P. G., Hideshima, T., Munshi, N., Treon, S. P., & Anderson, K. C. (2002) · Blood · doi:10.1182/blood.v99.11.4079 · Cited by 367
Condon, J. C., Jeyasuria, P., Faust, J. M., & Mendelson, C. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401124101 · Cited by 365
Sabroe, I., Prince, L. R., Jones, E. C., Horsburgh, M. J., Foster, S. J., Vogel, S. N., Dower, S. K., & Whyte, M. K. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.5268 · Cited by 351
Martelli, A. M., Nyåkern, M., Tabellini, G., Bortul, R., Tazzari, P. L., Evangelisti, C., & Cocco, L. (2006) · Leukemia · doi:10.1038/sj.leu.2404245 · Cited by 342
Peitz, M., Pfannkuche, K., Rajewsky, K., & Edenhofer, F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032068699 · Cited by 341
Microglial activation and amyloid‐β clearance induced by exogenous heat‐shock proteins
Kakimura, J.-I., Kitamura, Y., Takata, K., Umeki, M., Suzuki, S., Shibagaki, K., Taniguchi, T., Nomura, Y., Gebicke-Haerter, P. J., Smith, M. A., et al. (2002) · The FASEB Journal · doi:10.1096/fj.01-0530fje · Cited by 329
NF-κB Activation Is a Critical Regulator of Human Granulocyte Apoptosis in Vitro
Ward, C., Chilvers, E. R., Lawson, M. F., Pryde, J. G., Fujihara, S., Farrow, S. N., Haslett, C., & Rossi, A. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.7.4309 · Cited by 320
Inhibition of NF-κB induces apoptosis of KSHV-infected primary effusion lymphoma cells
Keller, S. A., Schattner, E. J., & Cesarman, E. (2000) · Blood · doi:10.1182/blood.v96.7.2537 · Cited by 315
Role for Activating Transcription Factor 3 in Stress-Induced β-Cell Apoptosis
Hartman, M. G., Lu, D., Kim, M.-L., Kociba, G. J., Shukri, T., Buteau, J., Wang, X., Frankel, W. L., Guttridge, D., Prentki, M., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.5721-5732.2004 · Cited by 313
Kawakami, A., Aikawa, M., Alcaide, P., Luscinskas, F. W., Libby, P., & Sacks, F. M. (2006) · Circulation · doi:10.1161/circulationaha.106.622514 · Cited by 305
Sorescu, G. P., Sykes, M., Weiss, D., Platt, M. O., Saha, A., Hwang, J., Boyd, N., Boo, Y. C., Vega, J. D., Taylor, W. R., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300703200 · Cited by 305
Tang, S., Leung, J. C. K., Abe, K., Chan, K. W., Chan, L. Y. Y., Chan, T. M., & Lai, K. N. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16079 · Cited by 296
Condon, J. C., Hardy, D. B., Kovaric, K., & Mendelson, C. R. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0242 · Cited by 288
Barber, A. J., Nakamura, M., Wolpert, E. B., Reiter, C. E. N., Seigel, G. M., Antonetti, D. A., & Gardner, T. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104738200 · Cited by 288
Notoya, K., Jovanovic, D. V., Reboul, P., Martel-Pelletier, J., Mineau, F., & Pelletier, J.-P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3402 · Cited by 284
Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides
Dissanayake, S., Denny, W. A., Gamage, S., & Sarojini, V. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.02.006 · Cited by 280
A Stepwise Dissection of the Intracellular Fate of Cationic Cell-penetrating Peptides
Fischer, R., Köhler, K., Fotin-Mleczek, M., & Brock, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311461200 · Cited by 278
Jazirehi, A. R., & Bonavida, B. (2005) · Oncogene · doi:10.1038/sj.onc.1208349 · Cited by 275
Farkhani, S. M., Valizadeh, A., Karami, H., Mohammadi, S., Sohrabi, N., & Badrzadeh, F. (2014) · Peptides · doi:10.1016/j.peptides.2014.04.015 · Cited by 273
Reissmann, S. (2014) · Journal of Peptide Science · doi:10.1002/psc.2672 · Cited by 266
Leclerc, E., Fritz, G., Weibel, M., Heizmann, C. W., & Galichet, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703951200 · Cited by 262
Cell-penetrating peptides transport therapeutics into cells
Ramsey, J. D., & Flynn, N. H. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.07.003 · Cited by 256
A femtomolar-acting neuroprotective peptide.
Brenneman, D. E., & Gozes, I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118672 · Cited by 256
Differences in signaling pathways by IL-1β and IL-18
Lee, J.-K., Kim, S.-H., Lewis, E. C., Azam, T., Reznikov, L. L., & Dinarello, C. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402800101 · Cited by 237
Tan, K. S., Nackley, A. G., Satterfield, K., Maixner, W., Diatchenko, L., & Flood, P. M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2006.06.007 · Cited by 204
The role of NF-κB/IκB proteins in cancer: implications for novel treatment strategies
Schwartz, S. A., Hernandez, A., & Mark Evers, B. (1999) · Surgical Oncology · doi:10.1016/s0960-7404(00)00012-8 · Cited by 132
Jantsch, J., Wiese, M., Schödel, J., Castiglione, K., Gläsner, J., Kolbe, S., Mole, D., Schleicher, U., Eckardt, K.-U., Hensel, M., et al. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.1210683 · Cited by 108
Importin-mediated retrograde transport of CREB2 from distal processes to the nucleus in neurons
Lai, K.-O., Zhao, Y., Ch'ng, T. H., & Martin, K. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803906105 · Cited by 106
Saika, S., Miyamoto, T., Yamanaka, O., Kato, T., Ohnishi, Y., Flanders, K. C., Ikeda, K., Nakajima, Y., Kao, W. W.-Y., Sato, M., et al. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62357-7 · Cited by 102
Pannaccione, A., Boscia, F., Scorziello, A., Adornetto, A., Castaldo, P., Sirabella, R., Taglialatela, M., Renzo, G. F. D., & Annunziato, L. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.034868 · Cited by 83
Thomas, P. G., Carter, M. R., Da’dara, A. A., DeSimone, T. M., & Harn, D. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2082 · Cited by 76
Inhibition of Aβ production by NF-κB inhibitors
Paris, D., Patel, N., Quadros, A., Linan, M., Bakshi, P., Ait-Ghezala, G., & Mullan, M. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2006.12.029 · Cited by 75
Lin, Z., Chen, C., Yang, D., Ding, J., Wang, G., & Ren, H. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-04002-1 · Cited by 49
“DJ-1 deficiency increases NF-κB-dependent microglial neurotoxicity To further confirm whether microglia activation by DJ-1 deficiency is NF-κB dependent, we examined the inflammatory response in DJ-1-deficient BV2 cells with SN-50, a specific NF-κB inhibitor that directly inhibits NF-κB nuclear transport [34].”
MethodIL-12 reverses anergy to T cell receptor triggering in human lung tumor-associated memory T cells
Broderick, L., Brooks, S. P., Takita, H., Baer, A. N., Bernstein, J. M., & Bankert, R. B. (2006) · Clinical Immunology · doi:10.1016/j.clim.2005.09.008 · Cited by 47
Computational Insights into Membrane Disruption by Cell-Penetrating Peptides
Catalina-Hernandez, E., Aguilella-Arzo, M., Peralvarez-Marin, A., & Lopez-Martin, M. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c01940 · Cited by 18
Metadata
- Authors
- Lin, Y.-Z., Yao, S., Veach, R. A., Torgerson, T. R., & Hawiger, J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1995-06
- Volume
- 270
- Issue
- 24
- Pages
- 14255-14258
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1965583590
- Cited by
- 918
- References
- 19
- FWCI
- 8.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.